Genome-Wide CRISPR Screening Identifies NAPRT as a Key Regulator of Human Adipogenesis
International Journal of Molecular Sciences · 14.11.2026 · 27 (22) · 10216
DOI: 10.3390/ijms272210216 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.11.2026. Verfasst von Ruipu Liang und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, the 111 Project, the Construction Project of Liaoning Provincial Key Laboratory, China.
Abstract (Originalsprache)
Adipocyte differentiation is central to adipose-tissue homeostasis, but its regulatory landscape remains incompletely defined in human cells. Here, we perform a genome-wide CRISPR/Cas9 knockout screen in oleic acid-differentiated human SW872 preadipocytes to identify functional regulators of white adipogenesis. The screens nominate hundreds of adipogenesis-regulating genes, and integration with human genetic evidence prioritizes nicotinate phosphoribosyltransferase (NAPRT) as a prominent player. NAPRT loss increases lipid accumulation and PPARγ abundance, reduces intracellular nicotinamide adenine dinucleotide (NAD+), and diminishes cytosolic β-catenin. Supplementation with nicotinamide mononucleotide restored NAD+ and partially reversed the signaling and adipogenic phenotypes, linking NAPRT-dependent NAD+ biosynthesis to WNT/β-catenin activity. Finally, deep learning-guided virtual screening nominates quinacrine as a candidate NAPRT inhibitor, and a lysate-based thermal shift assay shows quinacrine-dependent destabilization of NAPRT. These findings identify NAPRT as a metabolic regulator of human adipogenesis and connect NAD+ availability to WNT-dependent adipocyte fate control.
Förderung
- National Key Research and Development Program of China
- the 111 Project
- the Construction Project of Liaoning Provincial Key Laboratory, China
Zitieren
APA
Liang, R., Fan, S., Ma, S., Ma, W., Zuo, Z., Zhong, C., & Fei, T. (2026). Genome-Wide CRISPR Screening Identifies NAPRT as a Key Regulator of Human Adipogenesis. International Journal of Molecular Sciences, 27(22), 10216. https://doi.org/10.3390/ijms272210216
Vancouver
Liang R, Fan S, Ma S, Ma W, Zuo Z, Zhong C, et al. Genome-Wide CRISPR Screening Identifies NAPRT as a Key Regulator of Human Adipogenesis. International Journal of Molecular Sciences. 2026;27(22):10216. doi:10.3390/ijms272210216
BibTeX
@article{Liang2026,
author = {Liang, Ruipu and Fan, Shuangshuang and Ma, Shuwen and Ma, Wenqing and Zuo, Zhuo and Zhong, Chunge and Fei, Teng},
title = {Genome-Wide CRISPR Screening Identifies NAPRT as a Key Regulator of Human Adipogenesis},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {22},
pages = {10216},
doi = {10.3390/ijms272210216}
}
EUVIMED